Sophia Genetics has developed a new artificial intelligence clinical application for clinicians to use when analyzing liquid biopsy results. The new application utilizes the AI analytical platform SOPHiA to help clinicians diagnose cancer early by offering a standardized approach to DNA analysis in liquid biopsy testing; this approach was built on data mined from the network of hospitals already using Sophia Genetics' AI technology for genomic data analysis.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?